Original Source(s)
Related Content
ctDNA Tracks Relapse Risk in Breast Cancer
Personalized liquid biopsy testing identified molecular residual disease months before clinical recurrence
June 9, 2026
-
2 min
ASCO 2026: AI Challenges a Breast Cancer Standard
New data suggest AI-based analysis of pathology slides may provide additional prognostic information, particularly for patients in the intermediate-risk category
June 4, 2026
-
3 min